These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 1987537)

  • 1. Risks of alternate-day prednisone in patients with cystic fibrosis.
    Rosenstein BJ; Eigen H
    Pediatrics; 1991 Feb; 87(2):245-6. PubMed ID: 1987537
    [No Abstract]   [Full Text] [Related]  

  • 2. Alternate-day prednisone reduces morbidity and improves pulmonary function in cystic fibrosis.
    Auerbach HS; Williams M; Kirkpatrick JA; Colten HR
    Lancet; 1985 Sep; 2(8457):686-8. PubMed ID: 2863676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of airway inflammation in cystic fibrosis.
    Konstan MW
    Curr Opin Pulm Med; 1996 Nov; 2(6):452-6. PubMed ID: 9363184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternate-day prednisone in the maintenance immunosuppressive therapy after orthotopic liver transplantation.
    Pedrosa MC; Rohrer RM; Kaplan MM
    Clin Transplant; 1995 Aug; 9(4):322-5. PubMed ID: 7579741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of hypertonic saline, daily and alternate-day rhDNase in children with cystic fibrosis.
    Suri R; Wallis C; Bush A; Thompson S; Normand C; Flather M; Grieve R; Metcalfe C; Lees B
    Health Technol Assess; 2002; 6(34):iii, 1-60. PubMed ID: 12583821
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of prednisone dose spacing on plasma lipids.
    Galla JH; Curtis JJ; Woodford SY; Rees ED; Somes GW; Luke RG
    J Lab Clin Med; 1980 Jun; 95(6):801-7. PubMed ID: 6991620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practice parameter: corticosteroid treatment of Duchenne dystrophy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.
    Moxley RT; Ashwal S; Pandya S; Connolly A; Florence J; Mathews K; Baumbach L; McDonald C; Sussman M; Wade C; ;
    Neurology; 2005 Jan; 64(1):13-20. PubMed ID: 15642897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of refractory Evans syndrome with alternate-day cyclosporine and prednisone.
    Rackoff WR; Manno CS
    Am J Pediatr Hematol Oncol; 1994 May; 16(2):156-9. PubMed ID: 8166369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Oral ciprofloxacin therapy in juvenile patients with cystic fibrosis--results of a prospective pilot study].
    Sollich V; Klöditz E; Schuster R; Handrick W; Brömme S; Rumler W; Patsch R; Kharari H; Spencker FB
    Kinderarztl Prax; 1993 Aug; 61(6):211-4. PubMed ID: 8411847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting response to rhDNase and hypertonic saline in children with cystic fibrosis.
    Suri R; Metcalfe C; Wallis C; Bush A
    Pediatr Pulmonol; 2004 Apr; 37(4):305-10. PubMed ID: 15022126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternate-day prednisone therapy in IgA nephropathy. Preliminary analysis of a prospective, randomized, controlled trial.
    Julian BA; Barker C
    Contrib Nephrol; 1993; 104():198-206. PubMed ID: 8325030
    [No Abstract]   [Full Text] [Related]  

  • 12. Alternate-day prednisone therapy after orthotopic liver transplantation.
    Pedrosa MC; Rohrer RM; Kaplan MM
    N Engl J Med; 1991 Dec; 325(23):1658-9. PubMed ID: 1944462
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhaled tobramycin solution-associated recurrent eosinophilia and severe persistent bronchospasm in a patient with cystic fibrosis: a case report.
    Santos RP; Awa E; Anbar RD
    BMC Pediatr; 2007 Mar; 7():11. PubMed ID: 17331261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered steady state pharmacokinetics of levofloxacin in adult cystic fibrosis patients receiving calcium carbonate.
    Pai MP; Allen SE; Amsden GW
    J Cyst Fibros; 2006 Aug; 5(3):153-7. PubMed ID: 16481224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vision loss in giant cell arteritis patients treated with alternate-day corticosteroids: comment on the article by Hoffman et al.
    Spiera RF; Kupersmith M; Paget S; Spiera H
    Arthritis Rheum; 2003 Apr; 48(4):1159-60; author reply 1160-1. PubMed ID: 12687562
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antibiotic treatment strategies in cystic fibrosis].
    Smaczny C
    Pneumologie; 1996 Dec; 50 Suppl 3():831-3. PubMed ID: 9157437
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacologic management of cystic fibrosis.
    Wallace CS; Hall M; Kuhn RJ
    Clin Pharm; 1993 Sep; 12(9):657-74; quiz 700-1. PubMed ID: 8306566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non! to non-steroidal anti-inflammatory therapy for inflammatory lung disease in cystic fibrosis (at least at the moment).
    Bush A; Davies J
    J Pediatr; 2007 Sep; 151(3):228-30. PubMed ID: 17719925
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of pre-transplantation prednisone on survival after lung transplantation.
    McAnally KJ; Valentine VG; LaPlace SG; McFadden PM; Seoane L; Taylor DE
    J Heart Lung Transplant; 2006 Jan; 25(1):67-74. PubMed ID: 16399533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seat belt associated central line fracture--a previously unreported complication in cystic fibrosis.
    Ghayyda SN; Roland D; Cade A
    J Cyst Fibros; 2008 Sep; 7(5):448-9. PubMed ID: 18455967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.